Takeda broke into the record of high 20 publicly traded progressive pharma corporations after its $62 billion merger with Shire earlier this 12 months, in response to a brand new evaluation utilizing market capitalisation as a benchmark. Based on the evaluation from GlobalData, Takedaâ??s market cap grew to $63.four billion in Q1 this 12 months …